News
06-11-2008, 04:09 AM
New analysis of a drug approved for osteoporosis prevention and treatment has provided definitive evidence that the medication is also effective as a breast cancer preventative for certain cancers. Women who took the drug raloxifene were less likely to develop invasive, estrogen-receptor (ER) positive breast cancer compared with women who did not take the drug.
More... (http://www.medicalnewstoday.com/articles/110708.php)
More... (http://www.medicalnewstoday.com/articles/110708.php)